Clinical Trial Update: (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Z-Endoxifen in premenopausal women with ER-positive, HER2-negative breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Z-Endoxifen (endoxifen)

Snippet

Sponsor: Atossa Therapeutics, Inc. | Conditions: Breast Neoplasms, Invasive Breast Cancer | Phase 2 | Status: RECRUITING